National Institutes of Health logo
National Institutes of Health

A Holistic Approach to Study Non-Addictive Natural Products for Pain Management

Funds mechanistic research into how non-addictive natural products actually relieve chronic pain, across the whole body.

Millions of people already use botanicals, supplements and other natural products for pain, long before science has caught up with why — or whether — they work. This notice funds closing that gap, as part of the NIH HEAL Initiative's push for safe, non-addictive pain relief.

The scope is collaborative, interdisciplinary research into non-addictive natural products for chronic pain, taking a holis…

Collaborative, interdisciplinary, mechanistic research into non-addictive natural products (botanicals, dietary supplements and other naturally derived compounds) for chronic pain, examining coordinated action across digestive, immune, vascular, musculoskeletal, lymphatic, metabolic and nervous-system pathways, dose optimisation under a hormesis model, and intervention timing relative to the phases of pain and inflammation. Part of the NIH HEAL Initiative.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.25 May 2027
Decision timeiTypical time from the deadline to the funder's decision.26 weeks
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides →
FDA Office of Orphan Products Development logo
Open

Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases

🇺🇸FDA OOPD · United States

Funds natural-history studies that improve preparedness for rare disease trial pathways.

BiotechMedtech
$600KFeb'28
European Commission logo
Scheduled

Horizon Bio-CCU: Carbon to Products

🇪🇺European Commission · European Union

Funds two €6M projects that use biotechnology to purify captured carbon and turn it into sustainable feedstock for industrial products.

BiotechSynthetic Biology+2
€6MSep'27
National Institute on Alcohol Abuse and Alcoholism logo
Open

Prevention and Intervention Approaches for FASD (R34)

🇺🇸NIAAA · United States

Supports FASD prevention and intervention planning studies to establish feasibility and practical research direction.

MedtechBiotech
$450KJan'27
FDA — Food and Drug Administration logo
Open

Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases

FDA · United States

Funds natural history studies that track how a rare disease unfolds over time, to close data gaps blocking new treatments for it.

Biotech
$600KFeb'28
National Institute on Alcohol Abuse and Alcoholism logo
Open

Prevention and Intervention Approaches for FASD (R61/R33)

🇺🇸NIAAA · United States

Supports translational research for FASD prevention and intervention, moving through feasibility and expansion milestones.

MedtechBiotech
Nov'26
European Commission logo
Scheduled

Prevention and management of chronic non-communicable diseases in children and young people

🇪🇺European Commission · European Union

Funds implementation research that helps children and young people prevent and manage chronic disease equitably.

MedtechBiotech
€3M – €4MApr'27